Thus, the biological activities and tumor-promoting effects of endogenous IL-17-mediated inflammatory responses appear to be dependent on differences in local cytokine concentrations, bioavailability, and presence of select responding target tissues. The gene discussed is IL17A; the disease is neoplasm.